B. Taurisano

BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles

E. Borsi, E. Zamagni, C. Terragna, 2022, Computational and structural biotechnology journal.

Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients

D. Remondini, E. Borsi, E. Zamagni, 2022, International journal of molecular sciences.

The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases

E. Borsi, E. Zamagni, C. Papayannidis, 2022, Frontiers in Oncology.

High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients

E. Borsi, E. Zamagni, C. Terragna, 2023, Clinical and experimental medicine.

Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients

N. Manaresi, E. Borsi, E. Zamagni, 2024, Cancers.

Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients

E. Borsi, E. Zamagni, C. Terragna, 2024, Cells.

Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features

E. Borsi, E. Zamagni, N. Testoni, 2024, Nature communications.